Related Experiment Videos
Multiple myeloma
Robert A Kyle1, S Vincent Rajkumar
1Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA. kyle.robert@mayo.edu
The New England Journal of Medicine
|October 29, 2004
Summary
No abstract available in PubMed .
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Metaphase cytogenetics and plasma cell proliferation index for risk stratification in newly diagnosed multiple myeloma.
Blood advances·2020
Same author
The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied?
Blood cancer journal·2020
Same author
Monoclonal Gammopathy of Undetermined Significance: Indications for Prediagnostic Testing, Subsequent Diagnoses, and Follow-up Practice at Mayo Clinic.
Mayo Clinic proceedings·2020
Same author
Razi: Critical Thinker, and Pioneer of Infectious Disease and Ophthalmology.
Mayo Clinic proceedings·2020
Same author
Increased Bone Marrow Plasma-Cell Percentage Predicts Outcomes in Newly Diagnosed Multiple Myeloma Patients.
Clinical lymphoma, myeloma & leukemia·2020
Same journal
Ebola at 50 - Lessons for Outbreak Response and Preparedness.
The New England journal of medicine·2026
Same journal
Ianalumab plus Eltrombopag in Immune Thrombocytopenia. Reply.
The New England journal of medicine·2026
Same journal
Ianalumab plus Eltrombopag in Immune Thrombocytopenia.
The New England journal of medicine·2026
Same journal
Hypertension Control in Low-Income Patients. Reply.
The New England journal of medicine·2026